Drug Shortage Report for ONDANSETRON INJECTION USP
Report ID | 155950 |
Drug Identification Number | 02464578 |
Brand name | ONDANSETRON INJECTION USP |
Common or Proper name | ONDANSETRON INJECTION USP |
Company Name | STERIMAX INC |
Market Status | MARKETED |
Active Ingredient(s) | ONDANSETRON |
Strength(s) | 2MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 10 VIALS 2 ML |
ATC code | A04AA |
ATC description | ANTIEMETICS AND ANTINAUSEANTS |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | |
Actual start date | 2022-02-03 |
Estimated end date | |
Actual end date | 2022-04-08 |
Shortage status | Resolved |
Updated date | 2022-04-09 |
Company comments | Limited quantities remaining at McKesson. All hospital contracts have been covered by other Marketing Authorization holders. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2770 PORTLAND DRIVE OAKVILLE, ONTARIO CANADA L6H 6R4 |
Company contact information | 1-800-881-3550 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2022-04-09 | English | Compare |
v4 | 2022-04-07 | French | Compare |
v3 | 2022-04-07 | English | Compare |
v2 | 2022-03-03 | French | Compare |
v1 | 2022-03-03 | English | Compare |
Showing 1 to 5 of 5